4:55 PM
Feb 09, 2018
 |  BC Extra  |  Politics & Policy

CEA recommends pricing reforms at home and abroad

The Council of Economic Advisers issued a white paper proposing ways that the U.S. government can reduce drug prices while also fostering innovation. The paper included recommendations to reform policies that hinder price competition at home and implement policies to limit "free-riding" abroad.

The group said ex-U.S. drug developers and governments rely on U.S. patients and tax payers to finance R&D. It said that because most ex-U.S. governments -- as their...

Read the full 361 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >